Bill Summary
SB 1700 Prescribed Controlled Substances (2019 Session)
Prescribed Controlled Substances; Expanding the circumstances under which the Attorney General may request information from the prescription drug monitoring program to include an active investigation or pending civil or criminal litigation involving prescribed controlled substances; requiring the Department of Health to assign each patient a unique identifying number when releasing certain information; authorizing the Attorney General to introduce as evidence in certain actions specified information that is released to the Attorney General from the program’s records system, etc. Effective Date: Upon becoming a law
03/01/19
SENATE
Filed
03/08/19
SENATE
Referred to Health Policy; Judiciary; Rules
03/27/19
SENATE
On Committee agenda - Health Policy, 04/01/19, 1:30 pm, 412 K
04/01/19
SENATE
Favorable with CS by Health Policy; 10 Yeas, 0 Nays
04/02/19
SENATE
Committee Substitute Text (C1) Filed
04/03/19
SENATE
Now in Judiciary
04/03/19
SENATE
On Committee agenda - Judiciary, 04/08/19, 4:00 pm, 110 S
04/08/19
SENATE
Favorable by Judiciary; 5 Yeas, 1 Nay
04/09/19
SENATE
Now in Rules
05/02/19
SENATE
Withdrawn from Rules
05/02/19
SENATE
Placed on Calendar, on 2nd reading
05/02/19
SENATE
Placed on Special Order Calendar, 05/02/19
05/02/19
SENATE
Read Second Time; Substituted for HB 1253; Laid on Table, Refer to HB 1253
893.055
893.0551
Research & Reports
Revenue Estimating Coverence Reports, Veto, Transmittal letters and more. Learn more.
No reports related to this bill.
Upcoming Events
Florida's most comprehensive legislative calendar.
Learn more.
No events are scheduled at this time.
Press Releases
Related Press Announcements. Learn more.
No press releases related to this bill.
Features above are available to LobbyTools subscribers.
Request a free demo or call (850) 915-0100 ext. 2 to learn more.